Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis
- 9 October 2017
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 264 (12) , 2378-2386
Abstract
We aimed to assess suicidality risk amongst people who had had anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. All people with a definitive diagnosis of anti-NMDAR encephalitis in West China Hospital between June 2012 and February 2017 were identified and their notes were retrospectively reviewed. Demographic and clinical characteristics and risk predictors for suicidality were summarized; those with suicidality were compared to those without. 17 of 133 people (13%) presented with suicidality symptoms: 7 (5%) with suicidal ideation; 8 (6%) who attempted suicide; and 2 (1.5%) who completed suicide. Median age was 27 (16–78) years, most were female [13 (76%)]. Compared with those with no suicidality, psychiatric symptoms as the initial symptoms were more frequent in those who reported suicidality (p = 0.039); insomnia, aggression, mania, depression and delusion were also more common (p < 0.05). The use of antidepressants (p < 0.001) and recurrence of encephalitis (p = 0.020) were higher in people with suicidality than in those without. Other characteristics were not significantly different in those who had suicidality and those who did not. Suicidality is a common and potentially lethal risk for people with anti-NMDAR encephalitis. Those presenting with psychiatric symptoms as the initial symptom and with insomnia, aggression, mania, depression and delusion should be carefully screened for suicidality. Closely monitoring people who have been treated with antidepressants is necessary.Keywords
This publication has 41 references indexed in Scilit:
- Connecting inflammation with glutamate agonism in suicidalityNeuropsychopharmacology, 2012
- Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal DomainThe Journal of Neuroscience, 2012
- Reversible paraneoplastic encephalitis in three patients with ovarian neoplasmsActa Obstetricia et Gynecologica Scandinavica, 2012
- Anti-NMDA-Receptor Encephalitis: Case Report and Literature Review of an Under-Recognized ConditionJournal of General Internal Medicine, 2011
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Review: Suicide and schizophrenia: a systematic review of rates and risk factorsJournal of Psychopharmacology, 2010
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Suicide risk in schizophrenia: learning from the past to change the futureAnnals of General Psychiatry, 2007
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- A Rating Instrument For Anxiety DisordersPsychosomatics, 1971